Your session is about to expire
← Back to Search
tDCS for Cognitive Enhancement in Healthy Subjects (Normal_tDCS Trial)
N/A
Waitlist Available
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate (less than 60 minutes)
Awards & highlights
Normal_tDCS Trial Summary
This trial is testing the effects of tDCS on cognition in healthy volunteers.
Who is the study for?
This trial is for healthy volunteers without any history of neurological or psychiatric diseases, abnormal MRI results, metal implants, pacemakers, severe hypertension, cardiovascular disease or family history of epilepsy. Pregnant or breastfeeding women are also excluded.Check my eligibility
What is being tested?
The study tests the effects of transcranial direct current stimulation (tDCS) on brain function. Participants will undergo neuropsychological tests and brain imaging while receiving either real tDCS to left or right prefrontal cortex or sham (fake) tDCS.See study design
What are the potential side effects?
Potential side effects from tDCS may include mild discomfort at the stimulation site, itching, tingling sensation during application, headache after treatment and fatigue.
Normal_tDCS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediate (less than 60 minutes)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate (less than 60 minutes)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
functional connectivity
Secondary outcome measures
Stroop task performance
Normal_tDCS Trial Design
3Treatment groups
Active Control
Placebo Group
Group I: Real Left DLPFC tDCSActive Control1 Intervention
Real tDCS on the left dorsolateral prefrontal cortex
Group II: Real Right DLPFC tDCSActive Control1 Intervention
Real tDCS on the right dorsolateral prefrontal cortex
Group III: Sham tDCSPlacebo Group1 Intervention
30sec ramp-up and 30sec ramp-down
Find a Location
Who is running the clinical trial?
University of ManitobaLead Sponsor
592 Previous Clinical Trials
199,330 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have very high blood pressure.You have an unusual MRI result.You have metal implants or a pacemaker in your body.You have a heart or blood vessel condition.Your family members have a history of epilepsy.
Research Study Groups:
This trial has the following groups:- Group 1: Real Left DLPFC tDCS
- Group 2: Sham tDCS
- Group 3: Real Right DLPFC tDCS
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this trial still have room for more participants?
"Unfortunately, this study is not currently enrolling patients. Although, this was a recruiting study at one point in time, the last update to the posting on clinicaltrials.gov was on October 31st, 2022. There are 1,019 other trials that are actively recruiting patients right now."
Answered by AI
Share this study with friends
Copy Link
Messenger